Vaccines, blood, antisera, toxins and cultures in Belgium | The Observatory of Economic Complexity

About

Exports In 2022, Belgium exported $47.1B in Vaccines, blood, antisera, toxins and cultures, making it the 2nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most exported product in Belgium. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Belgium are: United States ($9.38B), Germany ($7.86B), Japan ($6.02B), United Kingdom ($2.72B), and France ($2.59B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Belgium between 2021 and 2022 were United States ($2.29B), Japan ($1.33B), and France ($662M).

Imports In 2022, Belgium imported $20.7B in Vaccines, blood, antisera, toxins and cultures, becoming the 3rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Belgium. Belgium imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($9.85B), France ($2.72B), United States ($1.9B), Switzerland ($1.61B), and Italy ($1.4B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Belgium between 2021 and 2022 were Ireland ($3.91B), France ($366M), and Italy ($63.4M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Belgium to the United States.

Latest Trends

December 2023

About

Overview In December 2023 Belgium's Vaccines, blood, antisera, toxins and cultures exports accounted up to €2.01B and imports accounted up to €1.66B, resulting in a positive trade balance of €354M. Between December 2022 and December 2023 the exports of Belgium's Vaccines, blood, antisera, toxins and cultures have decreased by €-859M (-29.9%) from €2.87B to €2.01B, while imports increased by €276M (19.9%) from €1.38B to €1.66B.

Destinations In December 2023, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (€572M), United Kingdom (€213M), Germany (€208M), France (€120M), and Italy (€95.1M), and were imported mostly from Ireland (€506M), Switzerland (€405M), United States (€365M), France (€73.4M), and Germany (€58.4M).

Growth In December 2023, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to France (€-179M or -52.6%), Italy (€-169M or -70.2%), and Canada (€-141M or -93.5%). In December 2023, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from United States (€944M or 2.66k%), Switzerland (€229M or 73.6%), and Austria (€44.6M or 482%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (December 2022 - December 2023)€-859M(-29.9%)

IMPORT GROWTH (December 2022 - December 2023)€276M(19.9%)

MAIN DESTINATION (December 2023)United States€572M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Belgium. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download